antimetabolites, antineoplastic

Preferred Label : antimetabolites, antineoplastic;

MeSH definition : Antimetabolites that are useful in cancer chemotherapy.;

MeSH synonym : antineoplastic antimetabolites;

MeSH annotation : TN 4: relation to ANTINEOPLASTIC AGENTS;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000964;

UMLS CUI

C0003377;

ATC code(s)
- antimetabolites [ATC Code]
- folic acid analogues [ATC Code]
- purine analogues [ATC Code]
- pyrimidine analogues [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Antineoplastic antimetabolites [Bloc CIM-11]
Indexing information
- 2'-deoxy-5-fluorouridylyl-(5'-5')-3'-C-ethynylcytidine [MeSH Supplementary Concept]
Ne pas confondre avec
- anticarcinogenic agents [MeSH Descriptor]
Record concept(s)
- antimetabolites, antineoplastic [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-chloro-3'-deoxyadenosine [MeSH Supplementary Concept]
- 3-Deazauridine [MeSH Descriptor]
- 3-deazaguanine [MeSH Supplementary Concept]
- 5,6-dihydro-5-azacytidine [MeSH Supplementary Concept]
- 5-thio-D-glucose [MeSH Supplementary Concept]
- 6-thioguanosine [MeSH Supplementary Concept]
- 9-hydroxyellipticine [MeSH Supplementary Concept]
- Capecitabine [MeSH Descriptor]
- Clofarabine [MeSH Descriptor]
- DFP-11207 [MeSH Supplementary Concept]
- Decitabine [MeSH Descriptor]
- Gemcitabine [MeSH Descriptor]
- L-methionine gamma-lyase [MeSH Supplementary Concept]
- MDH-7 compound [MeSH Supplementary Concept]
- Mercaptopurine [MeSH Descriptor]
- S 1 (combination) [MeSH Supplementary Concept]
- acivicin [MeSH Supplementary Concept]
- ancitabine [MeSH Descriptor]
- azacitidine [MeSH Descriptor]
- azaguanine [MeSH Descriptor]
- azaserine [MeSH Descriptor]
- azathioprine [MeSH Descriptor]
- azauridine [MeSH Descriptor]
- bromodeoxyuridine [MeSH Descriptor]
- buthionine sulfoximine [MeSH Descriptor]
- cytarabine [MeSH Descriptor]
- decitabine and cedazuridine drug combination [MeSH Supplementary Concept]
- diazooxonorleucine [MeSH Descriptor]
- doxifluridine [MeSH Supplementary Concept]
- floxuridine [MeSH Descriptor]
- fludarabine phosphate [MeSH Supplementary Concept]
- fluorouracil [MeSH Descriptor]
- lometrexol [MeSH Supplementary Concept]
- methotrexate [MeSH Descriptor]
- nolatrexed [MeSH Supplementary Concept]
- peptichemio [MeSH Descriptor]
- phenylacetic acid [MeSH Supplementary Concept]
- puromycin [MeSH Descriptor]
- puromycin aminonucleoside [MeSH Descriptor]
- pyrazofurin [MeSH Supplementary Concept]
- raltitrexed [MeSH Supplementary Concept]
- sparfosic acid [MeSH Supplementary Concept]
- tegafur [MeSH Descriptor]
- thioguanine [MeSH Descriptor]
- thioinosine [MeSH Descriptor]
- tiazofurin [MeSH Supplementary Concept]
- toyocamycin [MeSH Descriptor]
- trimetrexate [MeSH Descriptor]
- tubercidin [MeSH Descriptor]
UMLS correspondences (same concept)
- Antineoplastic antimetabolites [Bloc CIM-11]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients